Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells (Q43130700)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 March 2010
edit
Language Label Description Also known as
English
Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells
scientific article published on 17 March 2010

    Statements

    Rosiglitazone enhances the radiosensitivity of p53-mutant HT-29 human colorectal cancer cells (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit